Composition comprising recombinant human thyroid stimulating hormone and method for producing recombinant human thyroid stimulating hormone
US11001620B2 · kind B2 · utility
0Cited by
1References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 4, 2016 |
| Grant date | May 11, 2021 |
| Priority date | — |
| Expiry date | Mar 21, 2037 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a composition for the diagnosis and treatment of recurrent thyroid cancer comprising recombinant human thyroid stimulating hormone (rhTSH) and a method for producing the recombinant human thyroid hormone. The method for producing recombinant human thyroid hormone according to the present invention can effectively produce rhTSH despite being cultured through fed-batch culture, and has a high purification yield and purity. Therefore, the recombinant thyroid stimulating hormone produced by the method can be usefully used for the diagnosis or treatment of recurrent thyroid cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.